Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
about
Sulfasalazine for ankylosing spondylitis2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisPharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapiesOld and new treatment targets in axial spondyloarthritisIs there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study.Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.Update on the treatment of ankylosing spondylitis.Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialPredictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.Ankylosing spondylitis: recent breakthroughs in diagnosis and treatmentDouble-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvementDevelopments in the scientific and clinical understanding of the spondyloarthritidesInfliximab in the treatment of ankylosing spondylitis.Current therapeutics for spondyloarthritis.First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.Review: Nonradiographic axial spondyloarthritis: new definition of an old disease?How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).Toward a Mechanism-Based Approach to Pain Diagnosis.Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.Etanercept for treating axial spondyloarthritis.Etanercept for the treatment of non-radiographic axial spondyloarthritis.Golimumab for treatment of axial spondyloarthritis.Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.Management of patients with inflammatory bowel disease and spondyloarthritis.Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over tEfficacy of an acquainted drug in the treatment of inflammatory low back pain: sulfasalazine under investigation.Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study.Axial spondyloarthritis: is there a treatment of choice?Adalimumab for the treatment of ankylosing spondylitis.Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort.TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.[Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].Axial spondyloarthritis.[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].[Early therapy of axial spondyloarthritis and relevance of radiological progression].2014 European Guideline on the management of sexually acquired reactive arthritis.
P2860
Q24187791-D9A5E44D-7E4F-4E24-8E8A-5779EE64D4C2Q24603648-26B8D318-33EB-438C-9251-9E1EA15B6D2BQ26777084-AE45705C-4A17-49E3-AC62-2CB9D26942B6Q26777906-DF475179-D38A-4485-97E6-45FA6B51E63DQ30750448-FA186B36-B976-4B04-A0C3-AFC8C95E120FQ33766318-5B4817FE-360E-4A5E-89F4-160E38ACD641Q34449888-B24A2D05-6D29-4584-8D2C-8FA54597AF27Q34592673-FDC2EFAE-BD9B-4304-8E25-1A7E60E875EFQ35537104-D88B4602-4B96-40F2-B17A-01835246FB7DQ35708834-F2E4D659-EC82-4401-BAC8-DED062C59975Q36143588-A5FDFB89-4B3D-4687-9F5F-2877B84C5307Q36633259-F4C97FDF-BFC4-4CC1-B956-A0E33ADADC1EQ37207018-4D80D777-B054-44E4-A5FE-E4A55D7687A7Q37290474-10A013D0-CC82-497A-89F5-9C9694202962Q37944297-E086CDD5-2730-4A9D-BB27-26E88679F5C5Q38003531-0AEFF085-0859-476A-A597-AF97DFF27EABQ38066807-18E8A685-0009-49FB-8C5D-65857DF1C7A6Q38120525-B2396825-5A0D-4FE9-9CE7-D894FDB1330CQ38145501-F83FE5DB-75DB-4A84-A785-29705B69C3B7Q38438153-4FDBA83B-DE3C-4F54-BBD9-0C302B6CF467Q38559303-B67A3BD3-C488-46E3-B41E-5B3796281A78Q38611064-90065F84-82FA-42BB-B730-C8319206C333Q38691419-D2D62206-808B-4043-8567-4FF82D274244Q38703849-06F293DB-2F7E-4AD0-BEFC-1D82CE351F40Q38707718-34FEEA86-1A54-41C2-A96D-6F13BE92F030Q39135959-BC644EF3-74A4-4BE3-835E-75FE22185C21Q40054186-C78638CA-AE27-4815-8AC7-31388BCF9B64Q40164708-99F3A97F-6B9E-44CE-BA99-4C0BDB75251DQ41227254-AAF32CB2-F794-4EAF-BC53-9D152DFB533DQ41921185-AE62AF4F-E68E-461F-AFF4-03EEE6AF0790Q42013856-62656532-0C73-4370-BC2F-08146C684B6EQ42616837-D1F3BE0A-40AF-4593-8AC7-908EAF72FAA8Q46052645-59B9E388-2578-4001-B24A-1AADA7C3E57FQ48628994-FD7CB182-7E82-4DE4-915E-262663C7EB38Q51287271-2CFB0015-1211-4CF5-B5DA-DF85C4C7B8EFQ52844712-CEE3E4ED-A561-4542-9FB8-27623F4D5D6FQ52870848-089E5576-22A0-49F4-A945-37050C32BE07Q52874129-9A77852B-074A-4C62-A23F-1B50467F7E50Q52889934-EBCB0958-993A-434C-9EAF-51026E901BBCQ53272760-0845171C-11B4-4071-BF6A-4BA2FA6920C4
P2860
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@ast
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@en
type
label
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@ast
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@en
prefLabel
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@ast
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@en
P2093
P2860
P356
P1476
Efficacy of sulfasalazine in p ...... e randomised controlled trial.
@en
P2093
P2860
P304
P356
10.1136/ARD.2006.052878
P407
P577
2006-04-10T00:00:00Z